ArticlePloS one2026
Targeted metabolomic profiling of RAW 264.7 cells infected with Brucella canis identifies time-dependent metabolic changes.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canine brucellosis caused by Brucella canis is gaining public-health relevance as companion-dog ownership and close human-animal contact increase. Yet mechanistic insight into B. canis host responses remains limited at the pathway level. To address this gap, we profiled infection-associated metabolic responses in RAW 264.7 cells across multiple post-infection time points using targeted metabolomics (CE-MS). We observed a coherent, time-ordered pattern with the largest shifts at 24 h: arginine, hydroxyproline, choline, cysteine, β-alanine, and glycerol-3-phosphate showed pronounced decreases, and tyrosine decreased modestly; α-ketoglutarate displayed a lower mean at 12 h. Unsupervised analyses separated infected and control groups over time (PCA PC1 = 59.4%, PC2 = 16.7%; 76.1% cumulative), providing an orthogonal summary of the temporal divergence. A supplementary sensitivity analysis (Minimum Cell Loss) was included as exploratory contextual information regarding potential cell-number effects, although direct measurements of infection efficiency and macrophage viability were not performed. An integrated pathway schematic summarizes metabolite associations related to nitric-oxide-related, mitochondrial/energy, redox/glutathione, extracellular-matrix, membrane-lipid, and neuroimmune-related pathways. Together, these results deliver a time-resolved view of B. canis-macrophage metabolic responses and delineate prioritized avenues for targeted mechanistic validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.